Meyerovich Medical & Diagnostic P C Rego Park, NY - 11374

Meyerovich Medical & Diagnostic P C is categorized under Doctors in Rego Park, NY and active since 2002.

Meyerovich Medical & Diagnostic P C was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Inessa Meyerovich at the company’s single location by writing to 9811 Queens Boulevard # 1e, Rego Park, New York NY 11374 or by phoning (718) 830-0400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Meyerovich Medical & Diagnostic P C
Contact Person: Inessa Meyerovich
Address: 9811 Queens Boulevard # 1e, Rego Park, New York 11374
Phone Number: (718) 830-0400
Annual Revenue (USD): $100.000 to $499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Meyerovich Medical & Diagnostic P C was started in 2002 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Inessa Meyerovich for inquiries that concern Meyerovich Medical & Diagnostic P C by calling the company number (718) 830-0400, as your correspondence is most welcome. Additionally, the physical location of the single location of Meyerovich Medical & Diagnostic P C can be found at the coordinates 40.728722,-73.857531 as well as the street address 9811 Queens Boulevard # 1e in Rego Park, New York 11374.

For its online presence, you may visit Meyerovich Medical & Diagnostic P C’s website at and engage with its social media outlets through on Twitter and on Facebook.